187 related articles for article (PubMed ID: 37086083)
1. 24-hour ambulatory blood pressure and cryptogenic ischemic stroke in young adults.
Tulkki L; Martinez-Majander N; Haapalahti P; Tolppanen H; Sinisalo J; Repo O; Sarkanen T; Numminen H; Ryödi E; Ylikotila P; Roine RO; Lautamäki R; Saraste A; Miettinen T; Autere J; Jäkälä P; Hedman M; Huhtakangas J; Junttola U; Putaala J; Pirinen J;
Ann Med; 2023 Dec; 55(1):2203513. PubMed ID: 37086083
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
Mazzucco S; Li L; Rothwell PM
JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
[TBL] [Abstract][Full Text] [Related]
3. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular non-compaction as a potential source for cryptogenic ischemic stroke in the young: A case-control study.
Pöyhönen P; Kuusisto J; Järvinen V; Pirinen J; Räty H; Lehmonen L; Paakkanen R; Martinez-Majander N; Putaala J; Sinisalo J
PLoS One; 2020; 15(8):e0237228. PubMed ID: 32797064
[TBL] [Abstract][Full Text] [Related]
5. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
[TBL] [Abstract][Full Text] [Related]
6. Histology of Cerebral Clots in Cryptogenic Stroke Varies According to the Presence of a Patent Foramen Ovale.
Härtl J; Berndt M; Poppert H; Liesche-Starnecker F; Steiger K; Wunderlich S; Boeckh-Behrens T; Ikenberg B
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012739
[TBL] [Abstract][Full Text] [Related]
7. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
[TBL] [Abstract][Full Text] [Related]
8. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
9. Differential lesion patterns on T2-weighted magnetic resonance imaging and fluid-attenuated inversion recovery sequences in cryptogenic stroke patients with patent foramen ovale.
Huang YY; Shao B; Ni XD; Li JC
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1690-5. PubMed ID: 24739592
[TBL] [Abstract][Full Text] [Related]
10. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic Stroke.
Shih EK; Beslow LA; Natarajan SS; Falkensammer CB; Messé SR; Ichord RN
Neurology; 2021 Nov; 97(21):e2096-e2102. PubMed ID: 34649876
[TBL] [Abstract][Full Text] [Related]
14. Patent Foramen Ovale and Cryptogenic Strokes in the Stroke in Young Fabry Patients Study.
Huber R; Grittner U; Weidemann F; Thijs V; Tanislav C; Enzinger C; Fazekas F; Wolf M; Hennerici MG; McCabe DJ; Putaala J; Tatlisumak T; Kessler C; von Sarnowski B; Martus P; Kolodny E; Norrving B; Rolfs A;
Stroke; 2017 Jan; 48(1):30-35. PubMed ID: 27899752
[TBL] [Abstract][Full Text] [Related]
15. Relation between the size of patent foramen ovale and the volume of acute cerebral ischemic lesion in young patients with cryptogenic ischemic stroke.
Benvenuti F; Meucci F; Vuolo L; Nistri R; Pracucci G; Picchioni A; Venturini G; Stolcova M; Failli Y; Nencini P; Di Mario C; Sarti C;
Neurol Sci; 2022 Jan; 43(1):453-458. PubMed ID: 34050831
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
Saver JL; Carroll JD; Thaler DE; Smalling RW; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2017 Sep; 377(11):1022-1032. PubMed ID: 28902590
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale.
Rodés-Cabau J; Noël M; Marrero A; Rivest D; Mackey A; Houde C; Bédard E; Larose E; Verreault S; Peticlerc M; Pibarot P; Bogaty P; Bertrand OF
Stroke; 2009 Feb; 40(2):419-25. PubMed ID: 19095992
[TBL] [Abstract][Full Text] [Related]
19. Differential Lesion Patterns on T2WI and FLAIR Sequences in Cryptogenic Stroke Patients With Patent Foramen Ovale.
Huang YY; Shao B; Ni XD; Li JC; Niu XT; Lin YS; Yan XX
Neurologist; 2015 Nov; 20(5):75-9. PubMed ID: 26566038
[TBL] [Abstract][Full Text] [Related]
20. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke.
Elgendy AY; Saver JL; Amin Z; Boudoulas KD; Carroll JD; Elgendy IY; Grunwald IQ; Gertz ZM; Hijazi ZM; Horlick EM; Kasner SE; Kent DM; Kumar P; Kavinsky CJ; Liebeskind DS; Lutsep H; Mojadidi MK; Messé SR; Mas JL; Mattle HP; Meier B; Mahmoud A; Mahmoud AN; Nietlispach F; Patel NK; Rhodes JF; Reisman M; Sommer RJ; Sievert H; Søndergaard L; Zaman MO; Thaler D; Tobis JM
JAMA Neurol; 2020 Jul; 77(7):878-886. PubMed ID: 32282016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
